Achlorhydria surgery

Revision as of 20:14, 6 July 2016 by Anthony Gallo (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Achlorhydria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Achlorhydria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Achlorhydria surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Achlorhydria surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Achlorhydria surgery

CDC on Achlorhydria surgery

Achlorhydria surgery in the news

Blogs on Achlorhydria surgery

Directions to Hospitals Treating Achlorhydria

Risk calculators and risk factors for Achlorhydria surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Surgery

Hypergastrinemia due to achlorhydria secondary to PPI therapy or resection of the gastric fundus is known to cause enterochromaffin-like (ECL) cells hyperplasia and gastric carcinoids. Surgery is the only potentially curative therapy for carcinoid tumors.

References

Template:WH Template:WS